The Efficacy of Trimethoprim in Wound Healing of Patients With Epidermolysis Bullosa

• Status: Completed
• Trial end date: 2007-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the efficacy of trimethoprim in promoting wound healing and decreasing blister formation in patients with Epidermolysis Bullosa.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The Hospital for Sick Children
• Treatments: Trimethoprim

Criteria

Inclusion Criteria:

• Patients younger than 20 years of age

• Diagnosis of Recessive Dystrophic Epidermis Bullosa (RDEB)or Junctional Epidermis Bullosa (JEB)

• Signed consent/assent form

Exclusion Criteria:

-Previous known allergy or intolerance to trimethoprim